J9354 HCPCS code: Injection, ado-trastuzumab emtansine, 1 mg
J9354 is the HCPCS Level II code for injection, ado-trastuzumab emtansine, 1 mg. In 2024 Medicare paid an average of $30.40 per service for J9354 across 1,330,260 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 600 per day on outpatient hospital claims. Medicare volume fell 30% from 2022 to 2024 (1,913,451 to 1,330,260 services). In 2024, about 1,246 clinicians billed Medicare for J9354 for 812 beneficiaries; California, Florida, Texas accounted for 35% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1D — Chemotherapy |
| Added | 2014-01-01 |
| Last action effective | 2014-01-01 |
Who bills J9354 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 1,246 |
| Medicare beneficiaries | 812 |
| States with claims | 27 |
| Share of services in top 3 states (California, Florida, Texas) | 35% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J9354, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 1,913,451 | 1,090 | $33.90 | $27.06 |
| 2023 | 1,485,836 | 861 | $36.27 | $28.89 |
| 2024 | 1,330,260 | 812 | $38.17 | $30.40 |
States with the most J9354 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| California | 165,792 | $30.47 |
| Florida | 157,628 | $30.32 |
| Texas | 108,282 | $30.61 |
| Maryland | 78,552 | $30.26 |
| Tennessee | 71,338 | $30.84 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 600 | Prescribing Information |
| practitioner claims | 600 | Prescribing Information |
What changed for J9354
- 2014-01-01: J9354 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J9354?
J9354 is the HCPCS Level II code for injection, ado-trastuzumab emtansine, 1 mg. Short descriptor: "Inj, ado-trastuzumab emt 1mg".
How much does Medicare pay for J9354?
In 2024, the average Medicare payment was $30.40 per service (average allowed $38.17).
Does Medicare cover J9354?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J9354 can be billed per day?
600 on outpatient hospital claims; 600 on practitioner claims (NCCI medically unlikely edits).
Related J93 codes
- J9300 — Injection, gemtuzumab ozogamicin, 5 mg
- J9301 — Injection, obinutuzumab, 10 mg
- J9302 — Injection, ofatumumab, 10 mg
- J9303 — Injection, panitumumab, 10 mg
- J9304 — Injection, pemetrexed (pemfexy), 10 mg
- J9305 — Injection, pemetrexed, not otherwise specified, 10 mg
- J9306 — Injection, pertuzumab, 1 mg
- J9307 — Injection, pralatrexate, 1 mg
- J9308 — Injection, ramucirumab, 5 mg
- J9309 — Injection, polatuzumab vedotin-piiq, 1 mg
- J9310 — Injection, rituximab, 100 mg
- J9311 — Injection, rituximab 10 mg and hyaluronidase
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J9354
- Watch J9354 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J9354
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.